Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description ───────────────────────────────────────────────────────────────────────────────────────────────────────────── 10.1 First Amendment to NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan. 104 Cover Page Interactive Data File (embedded with Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEUROONE MEDICAL TECHNOLOGIES CORPORATION Dated: April 3, 2026 By: /s/ David Rosa David Rosa Chief Executive Officer